Back to search
Invasive Pneumococcal Disease, Protection Against
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Pneumococcal Disease, Protection Against trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Pneumococcal Disease, Protection Against trials you may qualify forBefore the introduction of pneumonia vaccines in 2000, between 700,000 - 1 million children died each year as a result of infection with the bacteria Streptococ…
This study is assessing if a reduced dosing schedule (1+1) of the 13-valent pneumococcal conjugate vaccine (PCV13) is non-inferior to the currently used schedul…
This is a multicentre prospective audit to determine the incidence of immunodeficiency in children with IPD. Aims and/or research question of the project 1. T…
The objective of this study is to document the residual burden of acute upper respiratory infections (AURIs), acute lower respiratory infections (ALRIs), otitis…